Search Results - "Naslund, M J"

Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting by Naslund, M J, Gilsenan, A W, Midkiff, K D, Bown, A, Wolford, E T, Wang, J

“…Men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia often do not discuss their symptoms with their primary care physicians (PCPs)…”
Get more information

A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period by Naslund, M J, Carlson, A M, Williams, M J

“…We performed an analysis comparing the cost of medical management with TUNA therapy for a 5-year period. Published costs for tamsulosin, finasteride,…”
Get more information

Complications after radical retropubic prostatectomy in the medicare population by Benoit, Ronald M, Naslund, Michael J, Cohen, Jeffrey K

“…Objectives. Radical prostatectomy is the standard of care for the treatment of clinically localized prostate cancer in the appropriate patient. However, the…”
Get full text

Complications after prostate brachytherapy in the Medicare population by Benoit, Ronald M, Naslund, Michael J, Cohen, Jeffrey K

“…Objectives. Prostate brachytherapy is gaining in popularity among patients and physicians for the treatment of clinically localized prostate cancer. Although…”
Get full text

Managing enlarged prostate in primary care by Naslund, M J, Costa, F J, Miner, M M

“…Assessment and treatment of benign prostatic hyperplasia, or enlarged prostate, has evolved considerably in recent years; clear evidence has accumulated for…”
Get more information

A quantitative analysis of the costs and benefits of prostate cancer screening by Benoit, R M, Grönberg, H, Naslund, M J

“…The present study attempts to quantitate in an economically and clinically meaningful manner the cost and cost-effectiveness of prostate cancer screening and…”
Get full text

Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study by Roehrborn, Claus G., Issa, Muta M., Bruskewitz, Reginald C., Naslund, Michael J., Oesterling, Joseph E., Perez-Marrero, Ramon, Shumaker, Bryan P., Narayan, Perinchery

“…Objectives. To report the safety and efficacy of the transurethral needle ablation (TUNA) procedure for the treatment of clinical benign prostatic hyperplasia…”
Get full text

The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis by Naslund, M J, Strandberg, J D, Coffey, D S

“…The etiology and pathogenesis of nonbacterial prostatitis remains unclear. This study provides evidence that genetic background, advancing age, and hormonal…”
Get more information

The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study by Roehrborn, C G, Burkhard, F C, Bruskewitz, R C, Issa, M M, Perez-Marrero, R, Naslund, M J, Shumaker, B P

“…We evaluated the effects of transurethral needle ablation and prostate resection on pressure flow urodynamic parameters in men with benign prostatic…”
Get more information

Application of argon beam coagulation in urological surgery by Quinlan, D M, Naslund, M J, Brendler, C B

“…Argon beam coagulation is a new form of electrocautery that has proved useful to control diffuse bleeding in other surgical specialties. We report its…”
Get more information

Transurethral needle ablation of the prostate by Naslund, Michael J.

Get full text

Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis by Hader, J E, Marzella, L, Myers, R A, Jacobs, S C, Naslund, M J

“…Acrolein is a toxic metabolite of cyclophosphamide that causes hemorrhagic cystitis in 2 to 40% of treated patients. Hyperbaric oxygen (HBO) is used to treat…”
Get more information

The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth by Naslund, M J, Coffey, D S

“…Physiologic surges of serum androgen, estrogen and progesterone normally occur in both rat and human males during the neonatal periods. The effect of these…”
Get more information

A comparison of complications between ultrasound-guided prostate brachytherapy and open prostate brachytherapy by Benoit, R M, Naslund, M J, Cohen, J K

“…Prostate brachytherapy has reemerged during the 1990s as a treatment for clinically localized prostate cancer. The renewed popularity of prostate brachytherapy…”
Get more information

Late invasive recurrence despite long-term surveillance for superficial bladder cancer by Thompson, Jr, R A, Campbell, Jr, E W, Kramer, H C, Jacobs, S C, Naslund, M J

“…Superficial transitional cell carcinoma of the bladder is associated with a 15 to 70% recurrence rate within 2 years. Most recurrences are superficial. A…”
Get more information

An economic rationale for prostate cancer screening by Benoit, R M, Naslund, M J

Get more information

Malignant renal schwannoma by Naslund, M J, Dement, S, Marshall, F F

“…Renal schwannomas are rare tumors. There have been only 4 cases (2 benign and 2 malignant) reported in the literature. We report a third case of a malignant…”
Get more information

Laparoscopy: its selected use in patients with unilateral nonpalpable testis after human chorionic gonadotropin stimulation by Naslund, M J, Gearhart, J P, Jeffs, R D

“…Laparoscopy has been used to help evaluate patients with a unilateral nonpalpable testis. This procedure can be performed quickly just before exploration with…”
Get more information

Small bowel obstruction following laparoscopic lymphadenectomy by Burney, T L, Jacobs, S C, Naslund, M J

“…We report 2 cases of small bowel obstruction following staging laparoscopic pelvic lymph node dissection for prostate adenocarcinoma. Short segments of ileum…”
Get more information

The socioeconomic implications of prostate-specific antigen screening by Benoit, R M, Naslund, M J

“…Widespread PSA screening will increase overall health care costs. This increase will not result from the detection of clinically insignificant prostate cancer,…”
Get more information